ScholarGate
助手

方法对比

并排查看您选择的方法;存在差异的行会高亮显示。

EORTC QLQ-C30:癌症生活质量评估的核心问卷×纤维肌痛影响问卷×
领域健康结局健康结局
方法族Process / pipelineProcess / pipeline
起源年份19931991
提出者Nico Aaronson et al.Cynthia S. Burckhardt et al.
类型Self-report quality of life questionnaireSelf-report symptom and functional impairment questionnaire
开创性文献Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376. DOI ↗Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The Fibromyalgia Impact Questionnaire: Development and validation. The Journal of Rheumatic Diseases, 18(5), 728-735. link ↗
别名QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life ScaleFIQ, Fibromyalgia Impact, Fibromyalgia Questionnaire
相关54
摘要The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care.The FIQ is the most widely used patient-reported outcome measure for fibromyalgia disease burden. Developed by Cynthia Burckhardt and colleagues in 1991, this 10-item questionnaire quantifies how fibromyalgia affects physical function, work capacity, depression, anxiety, sleep, pain, and fatigue. The revised version (FIQR, 21 items) offers enhanced psychometric properties and is the current standard in fibromyalgia clinical trials and practice.
ScholarGate数据集
  1. v1
  2. 3 来源
  3. PUBLISHED
  1. v1
  2. 3 来源
  3. PUBLISHED

前往搜索 下载幻灯片

ScholarGate方法对比: EORTC QLQ-C30 · FIQ. 于 2026-06-19 检索自 https://scholargate.app/zh/compare